← Eichor
Condition: Autoimmunity Inflammation Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Autoimmunity Inflammation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Montreal Immune-Related Adverse Events (MIRAE) Study
Phase N/A · 1 location(s) · Sir Mortimer B. Davis - Jewish General Hospital · NCT05139706Systemic Inflammation, Thyroid Autoimmunity and Neuroretinal Changes in Graves Disease
Phase N/A · 1 location(s) · Elazıg Fethi Sekin Sehir Hastanesi · NCT07480720Azathioprine in MOGAD
Phase 3 · 17 location(s) · Hospices Civils de Lyon · NCT05349006Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04902807The DANCEREX Proof-of-Concept Study for Chronic Neurological Disorders
NA · 3 location(s) · Fondazione Don Carlo Gnocchi ETS · NCT06112639"Effect of Vitamin E (α-Tocopherol) on Clinical Activity and Inflammation in Rheumatoid Arthritis"
Phase 2/Phase 3 · 2 location(s) · University of Guadalajara · NCT06915701Flemish Joint Effort for Biomarker PRofiling in Inflammatory Systemic Diseases
NA · 7 location(s) · University Hospital, Ghent · NCT05670301Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)
Phase N/A · 1 location(s) · Stefan Lujinschi · NCT07575347Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Phase N/A · 1 location(s) · Brain Inflammation Collaborative · NCT04806620A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumati
Phase 2 · 11 location(s) · SynAct Pharma Aps · NCT06671054Gfree - For Improved Blood Sugar and Reduced Inflammation.
NA · 2 location(s) · Göteborg University · NCT05894746Prospective Study of White Blood Cells
Phase N/A · 1 location(s) · Quell Therapeutics Limited · NCT04838171The MICRON Study - A Steno 1 Substudy
Phase N/A · 5 location(s) · University of Aarhus · NCT07270172Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00794352Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques
Phase 2 · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT02784210This Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA
Phase N/A · 1 location(s) · Washington University School of Medicine · NCT07115017Vancomycin Study in Multiple Sclerosis (MS)
Phase 1 · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT05539729Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes
NA · 1 location(s) · University of Virginia · NCT05653518Human Amniotic Mesenchymal Cell Secretome for Neurodegeneration and Neuroinflammation
NA · 2 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06551649Biomarkers of Synaptic Damage in Multiple Sclerosis
Phase N/A · 1 location(s) · Neuromed IRCCS · NCT03217396Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, a
Phase N/A · 1 location(s) · National Institute of Arthritis and Musculoskeletal and Skin · NCT03510442Secukinumab Open Label Roll-over Extension Protocol
Phase 4 · 167 location(s) · Novartis Pharmaceuticals · NCT04638647Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study
Phase N/A · 2 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06339177The Effect of Colchicine, on Insulin Sensitivity in Individuals With Type 1 Diabetes and Systemic Low-grade Inflammation
Phase 2 · 1 location(s) · Asger Lund, MD · NCT07247734Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
Phase N/A · 1 location(s) · Oregon Health and Science University · NCT07065747Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabo
Phase 1/Phase 2 · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT06032923ConsideRAte Study - Splenic Stimulation for RA
NA · 14 location(s) · Galvani Bioelectronics · NCT05003310The Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology.
NA · 1 location(s) · University Hospital, Clermont-Ferrand · NCT06426316Proteomic Biomarker Tests in Blood Samples from Children with Autism Spectrum Disorder (ASD)
Phase N/A · 1 location(s) · Benjamin Gesundheit · NCT02168868Safety of Splenic Stimulation for RA
NA · 2 location(s) · Galvani Bioelectronics · NCT04955899
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.